Cochlear stock: Citi keeps AUD 140.00 target for Cochlear stock
Published on 10/22/2026 at 20:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCiti target and quarterly figures
- Citi maintained a Hold rating and an AUD 140.00 target on October 20, 2026.
- Cochlear reported AUD 1.16 billion in quarterly revenue for the period ended June 30, 2026.
- Cochlear stock costs EUR 87.64 at Lang & Schwarz on October 22, 2026 at 8:11 p.m. CEST.
Cochlear Limited stock (ISIN AU000000COH5) was trading at EUR 87.64 at Lang & Schwarz on October 22, 2026 at 8:11 p.m. CEST. Citi maintained a Hold rating and an AUD 140.00 price target on October 20, 2026, according to The Globe and Mail.
Citi keeps its AUD 140.00 target
The latest Citi view places the target below the ASX quotation of AUD 140.59 on October 22, 2026 at 4:10 p.m. AEDT. UBS had maintained a Hold rating with an AUD 135.00 target on October 14, 2026, adding a second recent reference point for the hearing-implant maker, as reported by Markets Insider.
Quarterly revenue reached AUD 1.16 billion
Cochlear reported AUD 1.16 billion in revenue for the quarter ended June 30, 2026, compared with AUD 1.19 billion a year earlier. The same report carried a GAAP net loss of AUD 14.2 million against a net profit of AUD 183.8 million in the prior-year quarter, according to Markets Insider.
Stock sits below its yearly high
The ASX price of AUD 140.59 stood 52.58 percent below Cochlear's 52-week high of AUD 296.50 and 58.46 percent above its low of AUD 88.74 on October 22, 2026. Cochlear's market capitalization was AUD 9.2 billion, with 224,174 shares traded and a price-to-earnings ratio of 62.76.
Annual meeting is October 26
Cochlear's annual general meeting is scheduled for October 26, 2026, as a hybrid event, according to The Globe and Mail. The calendar date gives investors the next formal point for management communication after the fiscal 2026 results and the recent broker reviews.
Euro quotation remains the reference
At Lang & Schwarz, Cochlear stock was trading at EUR 87.64 on October 22, 2026 at 8:11 p.m. CEST. The ASX quotation was AUD 140.59 on October 22, 2026 at 4:10 p.m. AEDT.
The further course of trading is shown by the continuously updated real-time quote of Cochlear stock.
Cochlear stock at a glance
- Company: Cochlear Limited
- ISIN: AU000000COH5
- Ticker: COH
- Primary exchange: ASX
- Price Lang & Schwarz (as of October 22, 2026, 8:11 p.m. CEST): EUR 87.64
- Market capitalization: AUD 9.2 billion (as of October 22, 2026)
- 52-week range: AUD 88.74-296.50 (as of October 22, 2026)
- Sector / Industry: Healthcare / Medical Devices
Market context: Market report S&P/ASX 200.
